Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 11 Enz. Inhib. hit(s) with all data for entry = 6968
TargetKappa-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162697(US9056836, 11 | US9056836, 11/13 | US9056836, 13)
Affinity DataKi:  33.1nM ΔG°:  -42.7kJ/molepH: 7.4 T: 25°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetKappa-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162698(US9056836, 12)
Affinity DataKi:  42.5nM ΔG°:  -42.1kJ/molepH: 7.4 T: 25°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetKappa-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162696(US9056836, 10)
Affinity DataKi:  64.5nM ΔG°:  -41.0kJ/molepH: 7.4 T: 25°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetKappa-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162697(US9056836, 11 | US9056836, 11/13 | US9056836, 13)
Affinity DataKi:  66.8nM ΔG°:  -41.0kJ/molepH: 7.4 T: 25°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetKappa-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162701(US9056836, 22)
Affinity DataKi:  79.1nM ΔG°:  -40.5kJ/molepH: 7.4 T: 25°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetKappa-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162700(US9056836, 19)
Affinity DataKi:  89.6nM ΔG°:  -40.2kJ/molepH: 7.4 T: 25°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetMu-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162697(US9056836, 11 | US9056836, 11/13 | US9056836, 13)
Affinity DataKi:  621nM ΔG°:  -38.4kJ/molepH: 7.4 T: 50°CAssay Description:Radioligand dose-displacement binding assays for mu-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg membran...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetMu-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162698(US9056836, 12)
Affinity DataKi:  853nM ΔG°:  -37.5kJ/molepH: 7.4 T: 50°CAssay Description:Radioligand dose-displacement binding assays for mu-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg membran...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetMu-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162696(US9056836, 10)
Affinity DataKi:  977nM ΔG°:  -37.2kJ/molepH: 7.4 T: 50°CAssay Description:Radioligand dose-displacement binding assays for mu-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg membran...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetMu-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162697(US9056836, 11 | US9056836, 11/13 | US9056836, 13)
Affinity DataKi:  1.34E+3nM ΔG°:  -36.3kJ/molepH: 7.4 T: 50°CAssay Description:Radioligand dose-displacement binding assays for mu-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg membran...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetKappa-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM162697(US9056836, 11 | US9056836, 11/13 | US9056836, 13)
Affinity DataIC50:  66.8nMpH: 7.4 T: 25°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant ...More data for this Ligand-Target Pair
In DepthDetails US Patent